﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Society of Diabetic Nephropathy Prevention</PublisherName>
      <JournalTitle>Journal of Nephropathology</JournalTitle>
      <Issn>2251-8363</Issn>
      <Volume>14</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2025</Year>
        <Month>04</Month>
        <DAY>01</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>Association between systemic immune-inflammation index and risk of chronic kidney disease; a systematic review and meta-analysis</ArticleTitle>
    <FirstPage>e27613</FirstPage>
    <LastPage>e27613</LastPage>
    <ELocationID EIdType="doi">10.34172/jnp.2025.27613</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Sayed Yousef</FirstName>
        <LastName>Mojtahedi</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-6231-2662</Identifier>
      </Author>
      <Author>
        <FirstName>Reza</FirstName>
        <LastName>Tavakolizadeh</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0001-6544-6829</Identifier>
      </Author>
      <Author>
        <FirstName>Mohsen</FirstName>
        <LastName>Jafari</LastName>
      </Author>
      <Author>
        <FirstName>Hosein</FirstName>
        <LastName>Shabani-Mirzaee</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-6051-7509</Identifier>
      </Author>
      <Author>
        <FirstName>Maede</FirstName>
        <LastName>Safari</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-8610-8316</Identifier>
      </Author>
      <Author>
        <FirstName>Maryam</FirstName>
        <LastName>Ghodsi</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0001-8940-3970</Identifier>
      </Author>
      <Author>
        <FirstName>Masoumeh</FirstName>
        <LastName>Ghasempour Alamdari</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0003-1330-5789</Identifier>
      </Author>
      <Author>
        <FirstName>Niloufar</FirstName>
        <LastName>Ghanbari</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-3115-8324</Identifier>
      </Author>
      <Author>
        <FirstName>Paniz</FirstName>
        <LastName>Pourpashang</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0003-4469-086X</Identifier>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.34172/jnp.2025.27613</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2024</Year>
        <Month>12</Month>
        <Day>01</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2025</Year>
        <Month>02</Month>
        <Day>21</Day>
      </PubDate>
    </History>
    <Abstract>Introduction: Inflammation is a hallmark feature of chronic kidney disease (CKD) and the systemic immune-inflammation index (SII) is a potent biomarker for assessing the inflammatory status. Taking note of these, the present systematic review and meta-analysis evaluated the correlation between SII and the risk for CKD. Materials and Methods: ProQuest, Embase, PubMed, Web of Science, Cochrane, and Google Scholar databases were searched until November 20, 2024, without any restriction applied. Data were analyzed in Stata v14.0. The results with P&lt;0.05 were considered to be statistically significant. Results: Elevated SII values enhanced the overall risk of CKD (OR: 1.24; 95% CI: 1.52, 1.267), CKD risk in females (OR: 1.03; 95% CI: 1, 1.07), and CKD risk in the USA (OR: 1.27; 95% CI: 1.16, 1.38). Contrarily, no significant correlation was observed between SII and the risk for CKD among males (OR: 1.03; 95% CI: 0.99, 1.07) and in China (OR: 1.15; 95% CI: 0.98, 1.34). The second tertile (OR: 1.14; 95% CI: 1.05, 1.25), third tertile (OR: 1.49; 95% CI: 1.28, 1.73), third quartile (OR: 1.16; 95% CI: 1.08, 1.24), and fourth quartile (OR: 1.42; 95% CI: 1.27, 1.59) of the SII index enhanced the risk of CKD. Elevated SII values (OR: 1.43; 95% CI: 1.20, 1.70) enhanced the risk for CKD. Likewise, high SII values enhanced the risk for CKD in patients with diabetes mellitus (DM) (OR: 1.42; 95% CI: 1.21, 1.68), low-estimated glomerular filtration rate (eGFR) (OR: 1.27; 95% CI: 1.14, 1.40), and albuminuria (OR: 1.46; 95% CI: 1.08, 1.97), as well as in patients with BMI&gt;30 kg/m² (OR: 1.05; 95% CI: 1.01, 1.09). Conclusion: Elevated SII values enhanced the risk of CKD, and the SII-CKD association was intensified in females, Americans, and patients with DM, low eGFR, albuminuria, and obesity. Accordingly, high SII levels are a robust indicator of CKD prognosis. Registration: This study has been compiled based on the PRISMA checklist, and its protocol was registered on the PROSPERO (ID: CRD42024619311) and Research Registry (UIN: reviewregistry1925, ) websites.  </Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Systemic immune-inflammation</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">SII index</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Chronic renal disease</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Chronic kidney disease</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Renal insufficiency</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>